You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Methamphetamine and Stimulant Use

Cocaine and methamphetamine use rates and overdose deaths are rapidly increasing across the United States.  The National Institute of Drug Abuse released a report on methamphetamine in April 2019. Read the report. In addition, the Centers for Disease Control and Prevention released a report on patterns and characteristics of methamphetamine use among adults between 2015 and 2018 in March 2020. Read the report.

Stimulants Graph

The New England ATTC offers several training and technical assistance products to build workforce capacity in this high priority area. 

1) Stimulants and Their Impact on Brain and Behavior - Best Practices and Approaches for Effective Treatment and Recovery

The purpose of this daylong introductory level training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior. The day begins with a review of the latest data on the patterns and trends of stimulant use and availability in the United States and beyond, followed by a review of the mental and physical health consequences and cognitive impact of stimulant use. The training then explores the differential rates and impact of stimulant use on several populations and the relationship between stimulant use and HIV risk. The training concludes with a discussion of how to implement effective behavioral treatment interventions and recovery approaches when providing services to people with a stimulant use disorder.   Presented by: Taylor D'Addario, MA, LCDP and Robert Jope, LMHC

2) Project MIMIC (Maximizing Implementation of Motivational Incentives in Clinics)

Patients receiving methadone or buprenorphine who misuse stimulants have unique treatment needs.  In partnership with a NIDA-funded R01 (MPIs: Becker and Garner), the New England ATTC is helping opioid treatment programs throughout the region to implement contingency management, an evidence-based behavioral intervention for opioid use disorder that is also highly effective for patients with stimulant use disorder. Opioid treatment programs participating in Project MIMIC receive didactic training, performance feedback, and ongoing coaching. Programs interested in learning more about this technical assistance initiative should contact [email protected]  

3)  Stimulant Use Disorders: Epidemiology, Clinical Challenges, and Review of Treatments

This webinar reviews the rising prevalence of stimulant use disorders and discusses some of the unique clinical challenges presented by individuals who use stimulants. Evidence-based behavioral/psychosocial strategies are presented, along with pharmacotherapies currently considered promising. Presented by Dr. Richard Rawson.

4)  Implementation of Evidence-Based Treatments for Methamphetamine Dependenc

This workshop provides a more in-depth view of evidence-based behavioral/psychosocial strategies for stimulant use disorder, and considers key principles associated with implementing these treatments in practice. Presented by Dr. Richard Rawson.